234 related articles for article (PubMed ID: 33252744)
21. Phenylalanine-427 of anthrax protective antigen functions in both pore formation and protein translocation.
Sun J; Lang AE; Aktories K; Collier RJ
Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4346-51. PubMed ID: 18334631
[TBL] [Abstract][Full Text] [Related]
22. Activity of the Bacillus anthracis 20 kDa protective antigen component.
Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
[TBL] [Abstract][Full Text] [Related]
23. The Ins and Outs of Anthrax Toxin.
Friebe S; van der Goot FG; Bürgi J
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26978402
[TBL] [Abstract][Full Text] [Related]
24. Interactions between anthrax toxin receptors and protective antigen.
Scobie HM; Young JA
Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
[TBL] [Abstract][Full Text] [Related]
25. A semisynthesis platform for investigating structure-function relationships in the N-terminal domain of the anthrax Lethal Factor.
Pentelute BL; Barker AP; Janowiak BE; Kent SB; Collier RJ
ACS Chem Biol; 2010 Apr; 5(4):359-64. PubMed ID: 20180595
[TBL] [Abstract][Full Text] [Related]
26. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.
Liu S; Crown D; Miller-Randolph S; Moayeri M; Wang H; Hu H; Morley T; Leppla SH
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12424-9. PubMed ID: 19617532
[TBL] [Abstract][Full Text] [Related]
27. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
Chvyrkova I; Zhang XC; Terzyan S
Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure of a complex between anthrax toxin and its host cell receptor.
Santelli E; Bankston LA; Leppla SH; Liddington RC
Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
[TBL] [Abstract][Full Text] [Related]
29. Role of toxin functional domains in anthrax pathogenesis.
Brossier F; Weber-Levy M; Mock M; Sirard JC
Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
[TBL] [Abstract][Full Text] [Related]
30. Anthrax protective antigen: prepore-to-pore conversion.
Miller CJ; Elliott JL; Collier RJ
Biochemistry; 1999 Aug; 38(32):10432-41. PubMed ID: 10441138
[TBL] [Abstract][Full Text] [Related]
31. New aspects of the infection mechanisms of Bacillus anthracis.
Zakowska D; Bartoszcze M; Niemcewicz M; Bielawska-Drózd A; Kocik J
Ann Agric Environ Med; 2012; 19(4):613-8. PubMed ID: 23311776
[TBL] [Abstract][Full Text] [Related]
32. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice.
Liu S; Miller-Randolph S; Crown D; Moayeri M; Sastalla I; Okugawa S; Leppla SH
Cell Host Microbe; 2010 Nov; 8(5):455-62. PubMed ID: 21075356
[TBL] [Abstract][Full Text] [Related]
33. Calpain-dependent cytoskeletal rearrangement exploited for anthrax toxin endocytosis.
Jeong SY; Martchenko M; Cohen SN
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):E4007-15. PubMed ID: 24085852
[TBL] [Abstract][Full Text] [Related]
34. Peptide Probes Reveal a Hydrophobic Steric Ratchet in the Anthrax Toxin Protective Antigen Translocase.
Colby JM; Krantz BA
J Mol Biol; 2015 Nov; 427(22):3598-3606. PubMed ID: 26363343
[TBL] [Abstract][Full Text] [Related]
35. Anthrax protective antigen is a calcium-dependent serine protease.
Storm L; Bikker FJ; Nazmi K; Hulst AG; der Riet-Van Oeveren DV; Veerman ECI; Hays JP; Kaman WE
Virulence; 2018; 9(1):1085-1091. PubMed ID: 30052476
[TBL] [Abstract][Full Text] [Related]
36. Role of residues constituting the 2beta1 strand of domain II in the biological activity of anthrax protective antigen.
Khanna H; Chopra AP; Arora N; Chaudhry A; Singh Y
FEMS Microbiol Lett; 2001 May; 199(1):27-31. PubMed ID: 11356563
[TBL] [Abstract][Full Text] [Related]
37. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.
Mogridge J; Cunningham K; Lacy DB; Mourez M; Collier RJ
Proc Natl Acad Sci U S A; 2002 May; 99(10):7045-8. PubMed ID: 11997437
[TBL] [Abstract][Full Text] [Related]
38. Anthrax toxin lethal factor domain 3 is highly mobile and responsive to ligand binding.
Maize KM; Kurbanov EK; De La Mora-Rey T; Geders TW; Hwang DJ; Walters MA; Johnson RL; Amin EA; Finzel BC
Acta Crystallogr D Biol Crystallogr; 2014 Nov; 70(Pt 11):2813-22. PubMed ID: 25372673
[TBL] [Abstract][Full Text] [Related]
39. Cryo-EM structure of the fully-loaded asymmetric anthrax lethal toxin in its heptameric pre-pore state.
Antoni C; Quentin D; Lang AE; Aktories K; Gatsogiannis C; Raunser S
PLoS Pathog; 2020 Aug; 16(8):e1008530. PubMed ID: 32810181
[TBL] [Abstract][Full Text] [Related]
40. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
